Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -20.30 | N/A |
PEG Ratio (TTM) | -0.78 | N/A |
P/S Ratio (TTM) | 0.37 | N/A |
P/B Ratio (TTM) | 1.82 | N/A |
P/FCF Ratio (TTM) | 9.10 | N/A |
Price to 5YR AVG Earnings Ratio | -39.99 | N/A |
Price to 5YR AVG FCF Ratio | -6,269.30 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.97% | N/A |
ROE (TTM) | -10.40% | N/A |
Net Profit Margin (TTM) | -1.63% | N/A |
ROIC 5YR AVG | -1.94% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -107.17% | 132.21% | 74.81% |
Revenue | 9.23% | 6.97% | 8.10% |
Net Income | -111.15% | 133.21% | 74.26% |
Cash Flow | 150.92% | 2,108.65% | 4,033.57% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.35 | N/A |
Quick Ratio (TTM) | 1.33 | N/A |
D/E Ratio (TTM) | 0.33 | N/A |
Interest Coverage (TTM) | 0.50 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 2.41 | N/A |
LTL to 5YR AVG FCF | -1,161.33 | N/A |
Shares Outstanding Growth 5YR AVG | 2.55% | N/A |